Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1989 Dec;340(6):626-32.
doi: 10.1007/BF00717737.

Comparison of characteristics of dopamine uptake and mazindol binding in mouse striatum

Affiliations
Comparative Study

Comparison of characteristics of dopamine uptake and mazindol binding in mouse striatum

I Zimányi et al. Naunyn Schmiedebergs Arch Pharmacol. 1989 Dec.

Abstract

Biochemical and pharmacological studies suggest that the binding of [3H]mazindol is functionally related to the dopamine uptake carrier complex in rodent striatum. In order to study further the relationship between the substrate recognition site for dopamine uptake and the high-affinity binding site for mazindol the uptake of [3H]dopamine and the binding of [3H]mazindol was studied in BALB/cBy mouse striatum in various buffers (Tris, HEPES, bicarbonate-phosphate). Kinetic analysis showed that the Kd of the binding of [3H]mazindol and the Km of the uptake of [3H]dopamine was changed by different sodium concentrations and/or by the presence of Tris, while the Bmax and the Vmax remained essentially the same. However, the shape of the Na+ dependency curves was not the same for mazindol binding and dopamine uptake in the various buffers. The inhibitory effect of other cations such as K+ and Tris was also different on binding and uptake under similar experimental circumstances. Dopamine did not slow down the dissociation of mazindol from its site and this effect was not sodium-sensitive. These complexities can be accommodated by a model that involves overlapping sites for mazindol and dopamine on the dopamine uptake carrier complex, and translocation-reorientation steps.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Neurochem. 1983 Jul;41(1):172-8 - PubMed
    1. J Neurochem. 1987 Jun;48(6):1887-96 - PubMed
    1. Life Sci. 1987 Dec 14;41(24):2645-54 - PubMed
    1. Biochem Pharmacol. 1986 Apr 1;35(7):1123-9 - PubMed
    1. Naunyn Schmiedebergs Arch Pharmacol. 1988 Jun;337(6):626-32 - PubMed

Publication types